← Human Trials & Peer-Reviewed Studies
Skeletal muscle strength in young Asian Indian females after vitamin D and calcium supplementation: a double-blind randomized controlled clinical trial.
Plain-language guide to PMID 22904178 (2012): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 22904178
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2012
- Study type
- Randomized Controlled Trial
- Authors
- Goswami R et al. (10 authors)
- DOI
- 10.1210/jc.2012-2340
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Their objective was to assess the effect of vitamin D and/or calcium on muscle strength in young adults with vitamin D deficiency.
Who Took Part
The age groups tagged for this paper are teenagers, young adults and adults, women only.
Assessment included hand grip (primary outcome) and pinch grip strength, distance walked in 6 min, dyspnea score, quality of life by Short Form (36) Health Survey (SP-36), serum 25(OH)D, 1,25-dihydroxyvitamin D, and intact PTH.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The researchers conducted a RCT using a factorial design at a tertiary-care center from September 2010 to April 2011.
What Was Measured
PubMed files the paper under topics including Age Factors, Asian People, Calcium, Dietary, Dietary Supplements, Exercise Test, Hand Strength and India.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2012 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.